Stocks · Health care · Biological Products, (No Diagnostic Substances)

ADMA BIOLOGICS, INC.

ADMA Clue Score77
United States Fiscal year ends December CIK 0001368514 Results filed 4 Nov 2026

What the insiders did Scheduled selling only

By person

10 insiders · 2 transactions
34.4×

Adam S. Grossman holds 34.4 times base salary in stock. $31.82M of shares against $925.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Adam S. Grossman last reported holding, valued at $12.00, the price Common Stock was last bought or sold at on the open market here, on 5 Nov 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Adam S Grossman
President and CEO
—
$1.76M (2) scheduled
−$1.76M
2,651,734
1.18%
$31.82M
+1.3%
Steve Elms
Director
—
—
—
2,143,750
0.9571%
$25.73M
−2.2%
Jerrold B Grossman
Director
—
—
—
520,284
0.2323%
$6.24M
+11.3%
Kaitlin M. Kestenberg-Messina
COO and SVP, Compliance
—
—
—
443,061
0.1978%
$5.32M
−0.8%
Young Kwon
Director
—
—
—
263,020
0.1174%
$3.16M
−0.1%
Brad L. Tade
CFO and Treasurer
—
—
—
232,940
0.1040%
$2.80M
+8.6%
Terry Kohler
CFO and Treasurer
—
—
—
143,149
0.0639%
$1.72M
+146.7%
Lawrence P. Guiheen
Director
—
—
—
135,520
0.0605%
$1.63M
+30.4%
Alison Cecily Finger
Director
—
—
—
45,619
0.0204%
$547.43K
+89.8%
Eduardo Rene Salas
Director
—
—
—
21,579
0.0096%
$258.95K
—